11. The EMD Serono/Merck KGaA toll-like receptors TLR7/TLR8 inhibitor M5049 is an oral, twice-daily anti-inflammatory agent currently in a Ph. I trial for Lupus. The molecule potently blocks both…
Home > M5049
this content is exclusive to
Premium members
Unlock this content with a Premium membership to read it now.